Strumento inattivo

Azioni AMT HOLDING

Azioni

Prezzo di chiusura Euronext Amsterdam Altri mercati azionari
- ^EUR	-

AMT HOLDING : Amsterdam Molecular Therapeutics Reports Full Year Results 2011	27/04/12
AMT HOLDING : Amsterdam Molecular Therapeutics rondt uitkering bij voorbaat van uniQure certificaten aan AMT aandeelhouders af	26/04/12
AMT HOLDING : Amsterdam Molecular Therapeutics Receives Further Opinion on Glybera® Marketing Authorisation Application	23/04/12
AMT HOLDING : Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene	27/09/10
AMT HOLDING : AMT's Marketing Authorisation Application voor Glybera(R) verloopt op schema	18/08/10

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+33,37%	50,85 Mrd
IQVIA HOLDINGS INC.	+1,55%	42,82 Mrd
LONZA GROUP AG	+48,94%	42,03 Mrd
CELLTRION, INC.	-4,22%	29,55 Mrd
ICON PUBLIC LIMITED COMPANY	+11,57%	26,11 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,00%	19,13 Mrd
BIO-TECHNE CORPORATION	+7,36%	13,05 Mrd
MEDPACE HOLDINGS, INC.	+28,30%	12,16 Mrd
UNITED THERAPEUTICS CORPORATION	+23,80%	12,08 Mrd